Related Experiment Videos
Thoracic infection caused by Streptococcus milleri
G Porta1, M Rodríguez-Carballeira, L Gómez
1Internal Medicine Service, Hospital Mútua de Terrassa, University of Barcelona, Spain.
Abstract:
The objective of this study was to increase our understanding of the importance of members of the Streptococcus milleri (SM) group as respiratory pathogens, by studying the epidemiological and clinical features of thoracic infections caused by this group and comparing the epidemiology and prognosis of empyema caused by SM with cases of pneumococcal aetiology. The clinical histories and microbiology reports were reviewed in 27 cases of thoracic infection caused by SM over a period of 8 yrs. Cases of pneumococcal empyema that occurred during the same period were also analysed. Diagnoses were made of cases of empyema, including six with pneumonia and one with pulmonary abscess, three cases of pneumonia and two of mediastinitis. In 17 cases, SM was the only pathogen isolated. There was a history of instrument or surgical procedures on the digestive or respiratory tract in 59%. Secondary bacteraemia was documented in three cases. The treatment administered, a combination of antibiotics and surgery, was successful in 22 of 27 (81%) of cases. All strains were susceptible to penicillin. When the characteristics of the empyemas caused by monomicrobial SM infection were compared with those of pneumococcal aetiology from the same period of study, significant differences were found with respect to age, origin of the infection and the need for surgery. In conclusion, thoracic infections caused by Streptococcus milleri are largely pleural. They are polymicrobial in one-third of cases, commonly acquired in hospital and, in most patients, associated with major surgery and/or surgical procedures of the respiratory or digestive tract. The empyema frequently requires thoracotomy for complete resolution.
Insights
Thoracic infections caused by Streptococcus milleri (SM) are often pleural and polymicrobial, frequently linked to hospital stays and digestive or respiratory tract procedures. Treatment combining antibiotics and surgery is effective, with SM strains susceptible to penicillin.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- The Streptococcus milleri (SM) group's role as respiratory pathogens requires further elucidation.
- Thoracic infections encompass a range of conditions including empyema, pneumonia, and mediastinitis.
Purpose of the Study:
- To understand the significance of Streptococcus milleri (SM) group in respiratory infections.
- To analyze epidemiological and clinical characteristics of SM-caused thoracic infections.
- To compare SM-related empyema with pneumococcal empyema regarding epidemiology and prognosis.
Main Methods:
- Retrospective review of 27 cases of thoracic infection caused by SM over 8 years.
- Analysis of clinical histories and microbiology reports.
- Comparison with concurrently occurring pneumococcal empyema cases.
Main Results:
- SM infections led to empyema (12), pneumonia (3), and mediastinitis (2).
- SM was the sole pathogen in 17 cases; 59% had prior digestive/respiratory tract procedures.
- Treatment success rate was 81% (22/27); all SM strains were penicillin-susceptible.
- SM empyema differed from pneumococcal empyema in age, infection origin, and surgical necessity.
Conclusions:
- Thoracic infections caused by SM are predominantly pleural, often polymicrobial, and hospital-acquired.
- These infections are frequently associated with major surgery or procedures on the respiratory/digestive tracts.
- SM-related empyema often necessitates thoracotomy for complete resolution.